Imcheck Therapeutics

Imcheck Therapeutics company information, Employees & Contact Information

ImCheck Therapeutics is designing and developing a new generation of immunotherapeutic antibodies targeting butyrophilins, a novel super-family of immunomodulators. As demonstrated by lead clinical-stage program ICT01, which has a mechanism of action to simultaneously modulate innate and adaptive immunity, ImCheck's “first-in-class” activating antibodies may be able to produce superior clinical results as compared to the first-generation of immune checkpoint inhibitors and, when used in combination, to overcome resistance to this group of agents. In addition, ImCheck’s antagonist antibodies are being evaluated as potential treatments for a range of autoimmune diseases. Co-founder of the Marseille Immunopole cluster, ImCheck benefits from support from Prof. Daniel Olive (INSERM, CNRS, Institut Paoli Calmettes, Aix-Marseille Université), a worldwide leader in γδ T cells and butyrophilins research; from the experience of an expert management team; and from the commitment of leading US and European investors.

Company Details

Employees
53
Founded
-
Address
31 Chemin Joseph Aiguier Cs 70071, Marseille,provence-Alpes-Cote D'azur 13009,france
Phone
+33 4 13 96 14 90
Industry
Biotechnology
HQ
Marseille, Provence-Alpes-Cote d'Azur
Looking for a particular Imcheck Therapeutics employee's phone or email?

Imcheck Therapeutics Questions

News

Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology, strengthening its pipeline - GlobeNewswire

Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology, strengthening its pipeline GlobeNewswire

EQT Life Sciences’ ImCheck Therapeutics to be acquired by Ipsen in a transaction valued at up to EUR 1 billion - Cision News

EQT Life Sciences’ ImCheck Therapeutics to be acquired by Ipsen in a transaction valued at up to EUR 1 billion Cision News

Ipsen to acquire ImCheck Therapeutics in a deal worth up to €1bn - PMLiVE

Ipsen to acquire ImCheck Therapeutics in a deal worth up to €1bn PMLiVE

Ipsen to acquire ImCheck Therapeutics to strengthen oncology pipeline - Indian Pharma Post

Ipsen to acquire ImCheck Therapeutics to strengthen oncology pipeline Indian Pharma Post

Ipsen to acquire ImCheck Therapeutics For €1B - USA Herald

Ipsen to acquire ImCheck Therapeutics For €1B USA Herald

Ipsen expands oncology portfolio with €1B acquisition of French biotech ImCheck Therapeutics - Tech.eu

Ipsen expands oncology portfolio with €1B acquisition of French biotech ImCheck Therapeutics Tech.eu

France: Ipsen to strengthen oncology pipeline with ImCheck Therapeutics - Investors in Healthcare

France: Ipsen to strengthen oncology pipeline with ImCheck Therapeutics Investors in Healthcare

FDA Grants Orphan Drug Designation to ICT01 for Acute Myeloid Leukemia - OncLive

FDA Grants Orphan Drug Designation to ICT01 for Acute Myeloid Leukemia OncLive

ImCheck’s ICT01 Earns FDA Orphan Drug Designation for AML - Pharmacy Times

ImCheck’s ICT01 Earns FDA Orphan Drug Designation for AML Pharmacy Times

ImCheck Therapeutics - The Pharma Letter

ImCheck Therapeutics The Pharma Letter

ImCheck Therapeutics closes record €96 million financing round - Dentons

ImCheck Therapeutics closes record €96 million financing round Dentons

ImCheck Therapeutics Pitch Deck Used to Raise Series C - businessinsider.com

ImCheck Therapeutics Pitch Deck Used to Raise Series C businessinsider.com

ImCheck Therapeutics SAS raises €48m - European Biotechnology Magazine

ImCheck Therapeutics SAS raises €48m European Biotechnology Magazine

Ipsen Acquires ImCheck Therapeutics to Strengthen Oncology Pipeline - cointurk finance

Ipsen Acquires ImCheck Therapeutics to Strengthen Oncology Pipeline cointurk finance

Top Imcheck Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant